Press enter to begin your search

ValiRx - Company Update

VAL
Tue, 06 Feb 2018, 07:00 GMT

The ValiRX management team provides an update on VAL201, VAL301 and VAL401, and discusses the progress that has been made in the clinical trials.

Dr George Morris
Chief Operating Officer
VAL
Suzanne Dilly
CEO, ValiSeek Limited
VAL
Dr Satu Vainikka
Chief Executive Officer
VAL
Victoria D'Aquino
Research and Development Officer
VAL
5a734fcfb7715e3c91d7b6b2
SHOW MORE
FROM THIS COMPANY
ValiRx - Company Update
VAL Tue, 06 Feb 2018, 07:00 GMT

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

Industry: Health Care

Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/

The ValiRX management team provides an update on VAL201, VAL301 and VAL401, and discusses the progress that has been made in the clinical trials.

Dr George Morris
Chief Operating Officer
Suzanne Dilly
CEO, ValiSeek Limited
Dr Satu Vainikka
Chief Executive Officer
Victoria D'Aquino
Research and Development Officer
POWERED BY